Healthcare -
Biotechnology - NASDAQ - US
$ 23.46
-0.509 %
$ 3.38 B
Market Cap
-8.5
P/E
DNLI - TOTAL OTHER INCOME
Total Other Income DNLI - Denali Therapeutics Inc.
51.5 M
LAST VALUE
234.80%
2 YEAR CAGR
38.43%
5 YEAR CAGR
0.00%
10 YEAR CAGR